Credit: Shutterstock
June 9, 2025 07:00 AM EDT
Special

Who are the women re­shap­ing bio­phar­ma R&D? Nom­i­nate them for End­points' an­nu­al re­port

Nicole DeFeudis

Editor

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

HHS chief Kennedy re­moves all ACIP mem­bers, dis­man­tling vac­cine board

Up­dat­ed: Mer­ck wins FDA ap­proval for RSV an­ti­body drug, mak­ing a hot mar­ket more com­pet­i­tive

Biotech slump forces Re­silience to wind down six man­u­fac­tur­ing sites, us­ing bank­rupt­cy move

Mer­ck says its oral PC­SK9 in­hibitor ‘sig­nif­i­cant­ly’ cut cho­les­terol in two Phase 3 tri­als

In a break from oth­er biotechs, Twist Bio­science throws sup­port be­hind tar­iffs on syn­thet­ic DNA

sponsored

McKesson leads the charge in rev­o­lu­tion­iz­ing pre­ci­sion on­col­o­gy in com­mu­ni­ty prac­tices

A service from the Financial Times